Niacin receptor agonists, compositions containing such compounds and methods of treatment

Details for Australian Patent Application No. 2006236939 (hide)

Owner Merck & Co., Inc.

Inventors Imbriglio, Jason E.; Smenton, Abigail R.; Liang, Rui; Chan, Sook Yee; Schmidt, Darby R.; Colletti, Steven L.; Raghavan, Subharekha; Tata, James R.

Agent Spruson & Ferguson

Pub. Number AU-A-2006236939

PCT Pub. Number WO2006/113150

Priority 60/670,764 13.04.05 US

Filing date 7 April 2006

Wipo publication date 26 October 2006

International Classifications

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

C07D 257/00 (2006.01) Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

C07D 487/00 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

Event Publications

11 October 2007 PCT application entered the National Phase

  PCT publication WO2006/113150 Priority application(s): WO2006/113150

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

3 November 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006236940-Use of an epidermal growth factor receptor kinase inhibitor (EGFR) in gefitinib resistant patients

2006236933-Floor finish stripper composition that thickens following dilution with water and method of stripping